WASHINGTON-- Howard J. Federoff, MD, PhD, executive vice president of health sciences at Georgetown University Medical Center and executive dean of its School of Medicine, has been named a Charter Fellow of the National Academy of Inventors (NAI).
Election to NAI fellow status is a professional distinction accorded to academic inventors who have demonstrated a highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.
Academic inventors and innovators elected to the rank of NAI Charter Fellow were nominated by their peers for outstanding contributions to innovation in areas such as patents and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation.
Federoff conducts research and has several pending patent applications in the area of gene therapy and neurodegenerative diseases such as Parkinson's and Alzheimer's disease. He has significantly contributed to the field of gene therapy, using technology he developed called the HSV-amplicon system. This system allows the delivery of genes to the nervous system and the ability to manipulate their expression, which may make possible the treatment of numerous neurological disorders. Federoff also collaborates with scientists in the field of bioinformatics to develop novel approaches towards pre-symptomatic biomarker discovery, pharmacovigilance and healthcare delivery.
The NAI Fellows Selection Committee is comprised of 14 Members who are from the National Academies (National Academy of Sciences, National Academy of Engineering, Institute of Medicine), recipients of National Medals, a National Inventors Hall of Fame inductee, and senior officials from the United States Patent and Trademark Office (USPTO), the American Association for the Advancement of Science (AAAS), the Association of University Technology Managers (AUTM), the United Inventors Association and University Research Leadership.
The 98 innovators elected to NAI Fellow status represent 54 universities and non-profit research institutes. Together, they hold more than 3,200 U.S. patents.
Included in the Charter class are eight Nobel Laureates, two Fellows of the Royal Society, 12 presidents of research universities and non-profit research institutes, 50 members of the National Academies, 11 inductees of the National Inventors Hall of Fame, three recipients of the National Medal of Technology and Innovation, 4 recipients of the National Medal of Science, and 29 AAAS Fellows, among other awards and distinctions.
The NAI Charter Fellows will be inducted by the U.S. Commissioner for Patents, Margaret A. Focarino during the 2nd Annual Conference of the National Academy of Inventors on Feb. 22, 2013, in Tampa, Fla.
About the National Academy of Inventors
The National Academy of Inventors® is a 501c3 non-profit organization comprised of more than 45 U.S. and international universities and non-profit research institutes, with over 2,000 individual academic inventor members, and growing rapidly. It was founded in 2010 to recognize and encourage inventors with a patent issued from the U.S. Patent and Trademark Office, enhance the visibility of academic technology and innovation, encourage the disclosure of intellectual property, educate and mentor innovative students, and translate the inventions of its members to benefit society. The NAI publishes a newsletter andedits the multidisciplinary journal, Technology and Innovation – Proceedings of the National Academy of Inventors, published by Cognizant Communication Corporation (NY). www.academyofinventors.org
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization (BGRO), which accounts for the majority of externally funded research at GUMC including a Clinical Translation and Science Award from the National Institutes of Health. In fiscal year 2010-11, GUMC accounted for 85 percent of the university’s sponsored research funding.